Literature DB >> 16205639

Regulation of telomerase activity by the p53 family member p73.

M Beitzinger1, C Oswald, R Beinoraviciute-Kellner, T Stiewe.   

Abstract

The terminal ends of eukaryotic chromosomes, termed telomeres, progressively shorten during each round of cell division eventually leading cells into senescence. Tumor cells typically overcome this barrier to unlimited proliferation by activation of the human telomerase reverse transcriptase (hTERT) gene. In contrast, in most human somatic cells hTERT expression is tightly repressed by multiple tumor suppressors. Here, we studied the regulation of hTERT by the p53 family member p73. We show that forced expression of p73 or activation of endogenous p73 by E2F1 results in the downregulation of telomerase activity. Vice versa, siRNA-mediated knockdown of p73 induces hTERT expression. Responsiveness to p73 is conferred by Sp1 binding sites within the hTERT core promoter. In tumor cells, p73 isoforms lacking the transactivation domain (DeltaNp73) are frequently overexpressed and believed to function as oncogenes. We show that DeltaNp73 antagonizes the repressive effect of the proapoptotic p53 family members on hTERT expression and, in addition, induces hTERT expression in telomerase-negative cells by interfering with E2F-RB-mediated repression of the hTERT core promoter. These data provide evidence that the p73 gene functions as an important regulator of telomerase activity with implications for embryonic development, cellular differentiation and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16205639     DOI: 10.1038/sj.onc.1209125

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Differences in telomerase activity between colon and rectal cancer.

Authors:  Georgios D Ayiomamitis; George Notas; Apostolos Zaravinos; Adamantia Zizi-Sermpetzoglou; Maria Georgiadou; Ourania Sfakianaki; Elias Kouroumallis
Journal:  Can J Surg       Date:  2014-06       Impact factor: 2.089

2.  CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas.

Authors:  Wangbing Chen; Lijun Qin; Shusen Wang; Mei Li; Dingbo Shi; Yun Tian; Jingshu Wang; Lingyi Fu; Zhenglin Li; Wei Guo; Wendan Yu; Yuhui Yuan; Tiebang Kang; Wenlin Huang; Wuguo Deng
Journal:  Mol Oncol       Date:  2014-02-14       Impact factor: 6.603

3.  PinX1 inhibits telomerase activity in gastric cancer cells through Mad1/c-Myc pathway.

Authors:  Hong-bin Wang; Xing-wei Wang; Gang Zhou; Wei-qiang Wang; Yong-gang Sun; Shi-ming Yang; Dian-chun Fang
Journal:  J Gastrointest Surg       Date:  2010-06-11       Impact factor: 3.452

Review 4.  Tumor suppression by p53: making cells senescent.

Authors:  Yingjuan Qian; Xinbin Chen
Journal:  Histol Histopathol       Date:  2010-04       Impact factor: 2.303

Review 5.  A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.

Authors:  D Engelmann; C Meier; V Alla; B M Pützer
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

6.  NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells.

Authors:  Rachel A Katzenellenbogen; Erin M Egelkrout; Portia Vliet-Gregg; Lindy C Gewin; Philip R Gafken; Denise A Galloway
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

Review 7.  Novel ARF/p53-independent senescence pathways in cancer repression.

Authors:  Chia-Hsin Chan; Yuan Gao; Asad Moten; Hui-Kuan Lin
Journal:  J Mol Med (Berl)       Date:  2011-05-19       Impact factor: 4.599

8.  Tumor suppressors p53, p63TAα, p63TAy, p73α, and p73β use distinct pathways to repress telomerase expression.

Authors:  Yuan Yao; Marcia Bellon; Shary N Shelton; Christophe Nicot
Journal:  J Biol Chem       Date:  2012-04-10       Impact factor: 5.157

9.  Array-based multiplex analysis of DNA methylation in breast cancer tissues.

Authors:  Anatoliy A Melnikov; Denise M Scholtens; Elizabeth L Wiley; Seema A Khan; Victor V Levenson
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

10.  Sp1 and p73 activate PUMA following serum starvation.

Authors:  Lihua Ming; Tsukasa Sakaida; Wen Yue; Anupma Jha; Lin Zhang; Jian Yu
Journal:  Carcinogenesis       Date:  2008-06-25       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.